Loading data for BTMD — first visit, this takes a few seconds.
biote Corp. (BTMD)
NasdaqGM: BTMD
· Real-Time Price · USD
1.47
-0.02 (-1.34%)
At close: Aug 19, 2026, 3:59 PM
1.47
+0.00%
After-hours: 4:10 PM
biote Corp. (BTMD) Stock Price, Analysis & Data
-1.34% (1D)
| Bid | 1.62 |
| Market Cap | 49.83M |
| Revenue (ttm) | 183.53M |
| Net Income (ttm) | 5.86M |
| Beta | 1.65 |
| EPS (ttm) | 0.14 |
| PE Ratio (ttm) | 10.5 |
| Forward PE | 3.27 |
| P/B (ttm) | -0.64 |
| P/S (ttm) | 0.27 |
| Earnings Date | Nov 4, 2026 |
| Ask | 2.9 |
| Volume | 110,787 |
| Avg. Volume (20D) | 286,916 |
| Open | 1.47 |
| Previous Close | 1.49 |
| Day's Range | 1.46 - 1.50 |
| 52-Week Range | 1.27 - 3.62 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BTMD
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the h...
Industry Medical Care Facilities
Sector Healthcare
IPO Date Apr 28, 2021
Employees 223
Stock Exchange NasdaqGM
Ticker Symbol BTMD
Website https://www.biote.com
Financial Performance
In 2025, biote's revenue was 192.22M, a decrease of -2.52% compared to the previous year's 197.19M. Earnings were 27.05M, an increase of 756.67%.
Financial StatementsEarnings Surprise
biote has released their quarterly earnings on Aug 5, 2026:
biote Corp. is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2